Huang and colleagues show that in tumor-bearing individuals, increased circulating kynurenine results in megakaryocyte differentiation from megakaryocytic–erythroid progenitor cells by activating the aryl hydrocarbon receptor, resulting in increased expression of RUNX1. Here, RUNX1 is linked to neoplasm.